News & Events

Calendar of Events

Upcoming seminar and event information

 A rendering of people, sitting in chairs, in a lobby.

A historic investment from Board of Fellows member Israel Englander will advance Weill Cornell Medicine’s growing research enterprise and support critical initiatives throughout the institution.

The gift will expand the Englander Institute for Precision Medicine and bolster institutional biobanking services. Notably, it is also the first major gift that will support the construction of Weill Cornell Medicine’s new, state-of-the-art medical...

Read More
image of brain with electrode and nerve fibers

Five people who had life-altering, seemingly irreversible cognitive deficits following moderate to severe traumatic brain injuries showed substantial improvements in their cognition and quality of life after receiving an experimental form of deep brain stimulation (DBS) in a phase 1 clinical trial. The trial, reported Dec. 4 in Nature Medicine, was led by investigators at Weill Cornell Medicine, Stanford University, the...

Read More
Headshot of a woman on a gray background

Eileen Sheil, an accomplished leader in health care communications, has been appointed assistant vice provost for communications and public affairs for Weill Cornell Medicine, effective Feb. 1.

In her new role, Sheil will jointly lead the Office of External Affairs and oversee its more than 40-member Division of Communications and Public Affairs, which encompasses functions including editorial, multimedia, media relations, social media, marketing and brand, and government and community...

Read More
Alzheimer's disease symposium

The 11th annual Appel Alzheimer's Disease Research Institute Symposium brought together leading scientists and clinicians in the field to present the latest advances in understanding Alzheimer’s and related neurodegenerative diseases. The event was held at the Belfer Research Building on Nov. 9.

Helen and Robert Appel established the Institute in 2006 after they lost close friends to Alzheimer’s. “I am hopeful that we are closer than ever...

Read More

Awards & Honors: November 2023


Dr. John Leonard, senior associate dean for innovation and initiatives, interim chair of the Weill Department of Medicine, and the Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, was given the Lifetime Achievement Award from the Cancer Research and Treatment Fund. The organization funds research emphasizing the cause, prevention, treatment and cure of myeloproliferative neoplasms...

Read More
Generative AI illustration of a chihuahua

Researchers at Weill Cornell Medicine, Cornell Tech and Cornell's Ithaca campus have demonstrated the use of AI-selected natural images and AI-generated synthetic images as neuroscientific tools for probing the visual processing areas of the brain. The goal is to apply a data-driven approach to understand how vision is organized while potentially removing biases that may arise when looking at responses to a more limited set of researcher-selected images.

In the...

Read More
Three people sitting in chairs during a panel discussion

One of the hardest points on the translational road “from bench to bedside” can be the point where you have to turn over your discovery to a company you’ve founded—a company whose subsequent direction you won’t fully control.

“It’s sort of your baby that you’re turning over,” said Dr. Ronald Crystal, chair of the Department of Genetic Medicine and the Bruce Webster Professor of Internal Medicine at Weill Cornell Medicine, gene...

Read More
New York City buildings.

NEW YORK (Nov. 28, 2023)—Weill Cornell Medicine is dramatically expanding its campus and research footprint in New York City by securing five floors of 1334 York Ave., the current home of Sotheby's auction house, the institution announced today.

Located one block from Weill Cornell Medicine’s main campus on Manhattan’s Upper East Side, the site will add approximately 200,000 square feet of dedicated research space—an average of 40,000 square feet per floor—making it...

Read More
Bishoy Faltas

Dr. Bishoy M. Faltas, director of bladder cancer research at the Englander Institute for Precision Medicine at Weill Cornell Medicine, the Gellert Family-John P. Leonard, M.D. Research Scholar and an assistant professor of medicine at Weill Cornell Medicine has been awarded a $4 million, seven-year MERIT grant from the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

The “Method for Extending Research In Time” (...

Read More
caregiver appreciation day

Researchers from Weill Cornell Medicine provide the first national estimate of caregivers’ pain and arthritis experiences that can limit their ability to perform necessary tasks while caring for older family members. The study suggests screening caregivers for pain issues and offering interventions, particularly to populations that are traditionally underserved. This may help avoid higher health costs and improve the quality of life for both caregivers and their care recipients.


Read More
children playing tug-of-war

A team led by researchers at Weill Cornell Medicine has used an AI-based approach to uncover underlying patterns among the conditions in which people are born, grow, live, work, and age, termed social determinants of health (SDoH), and then linked each pattern to children’s health outcomes. Compared with traditional approaches, the strategy, in principle, provides a more objective and comprehensive picture of potential social factors that affect child health, which in turn, can enable better...

Read More
Headshot of a woman wearing a purple top and a black sweater.

Cathy Garzio, a distinguished academic medicine administrator, has been appointed executive vice provost and chief operating officer of Weill Cornell Medicine, effective early February.

In her new role at Weill Cornell Medicine, Garzio will oversee a portfolio of administrative departments including Human Resources, Facilities Management, Capital Planning and Construction, and Student and Faculty Housing, which collectively provide efficient daily operations for the institution’s...

Read More
Tanzania sharing information on family planning

Researchers at Weill Cornell Medicine found that partnering with local religious leaders boosted adoption of family planning methods in Tanzania. The findings present a novel strategy for increasing global awareness and use of contraception in regions where faith leaders are trusted messengers in the community.

The study, published in The Lancet Global Health on Nov. 14, showed that...

Read More
image of cells in bone marrow stained yellow, cyan and red

A team at Weill Cornell Medicine has mapped the location and spatial features of blood-forming cells within human bone marrow. Their findings confirm hypotheses about the anatomy of this tissue and provide a powerful new means to study diseases, ranging from noncancerous conditions, such as sickle cell anemia, to malignant conditions, such as acute leukemia, that affect bone marrow.  

For the...

Read More
photo of person wrapping blood pressure cuff around lower leg of patient

In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, which has been the standard treatment, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Angioplasty involves the widening of a narrowed artery with a small, balloon-like mechanism. A resorbable scaffold is a stent-like structure that props the artery open...

Read More
a yellow scientific image against a black backdrop

New York, NY (November 9, 2023) - The Allen Discovery Center (ADC) for Neuroimmune Interactions at the Icahn School of Medicine at Mount Sinai hopes to revolutionize the field of medicine with a groundbreaking project to understand how the human body senses health and disease.

Spearheaded by Dr. Brian S. Kim of Mount Sinai and co-led by Dr. David...

Read More
islet cell labeled with green for insulin and blue for nucleus

A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in type 2 diabetes, according to a new study by Weill Cornell Medicine investigators. The preclinical discovery, reported Nov. 9 in Nature Chemical Biology, provides a new chemical tool for probing the biology of diabetes, and...

Read More
insulin producing islet cells

Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with type 2 diabetes—a condition that affects more than half a billion people worldwide.

This study, published in the Journal of Clinical Investigation on Sept. 15...

Read More
beta amyloid around brain blood vessels

Researchers at Weill Cornell Medicine have demonstrated how amyloid beta, a peptide associated with Alzheimer’s disease, can interact with a protein receptor on immune cells in the brain triggering a reaction that damages blood vessels and leads to neurodegeneration.

The findings, published in Molecular Neurodegeneration on Oct. 3, may help researchers understand how dementia develops...

Read More
Prostate cancer treatment

Researchers at Weill Cornell Medicine have led a phase 1 trial of a new drug that delivers potent radiation therapy directly and specifically to cancer cells in patients with advanced prostate cancer. The clinical trial showed that the “radiopharmaceutical” was well tolerated and demonstrated promising antitumor activity, according to a new study published on Nov. 3 in the Journal of Clinical Oncology.


Read More

Government & Community Affairs 1300 York Ave., Box 314 New York, NY 10065